Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Ansan and Boehringer Inglheim enter apafant agreement

June 7, 1996

Single-dose hepatitis A vaccine available

June 7, 1996

Oral toxoid vaccine under development by OraVax

June 7, 1996

Commencement of SYNSORB Cd phase I trial expected

June 7, 1996

Centocor's CenTNF sees positive results

May 31, 1996

Nitto Boseki claims serine protease inhibitors

May 24, 1996

Tobishi CCK-A antagonists for pancreatitis

May 24, 1996

TravelGAM clinical results presented at ASM meeting

May 24, 1996

Orphan Medical obtains European marketing rights for Colomed

May 24, 1996

5-HT4 antagonist LY-353433: Potential treatment for GI disorders

May 24, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...